| 2018-03-12 |
1 |
|
infringement of U.S. Patent Nos. 6,174,442 (“the ’442
patent”) and 9,561,251 (“the ’251 patent”) (collectively…On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled
“Pharmaceutical compositions.… THE PATENTS-IN-SUIT
7. On January 16, 2001, the United States Patent and Trademark…Switzerland is the assignee of the ’442 patent. A copy of the ’442
patent is attached hereto as Exhibit A.
…is the assignee of the ’251 patent. A copy of the ’251
patent is attached hereto as Exhibit B.
|
External link to document |
| 2019-09-11 |
117 |
Complaint - Amended |
THE ’251 PATENT
7. On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled…This is an action for infringement of U.S. Patent No. 9,561,251 as corrected by
the Certificate of Correction… of Correction regarding the ’251 patent. A copy of the ’251 patent, as
corrected by the Certificate … in prior patent cases. On
information and belief, Lupin Atlantis has been sued for patent infringement… )
FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT
Plaintiffs Vifor Fresenius |
External link to document |
| 2020-08-13 |
256 |
Order - -Memorandum and Order |
claims 29, 30, 31 and 51 of U.S. Patent No. 9,561,251 (“the
’251 patent”). In connection with narrowing…this 13th day of August 2020:
This is a patent case brought by Plaintiffs Vifor Fresenius Medical…aware of when he submitted a declaration to the Patent Office in
2015. (D.I. 216 at 8-10). Defendants…signed and
submitted his sworn declarations” to the Patent Office. (D.I. 225 at 5 (emphasis in original)).…2018
2 September 2022
1:18-cv-00390
Patent - Abbreviated New Drug Application(ANDA)
Defendant |
External link to document |
| 2020-11-25 |
265 |
Complaint - Amended |
THE ’251 PATENT
7. On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled…This is an action for infringement of U.S. Patent No. 9,561,251 as corrected by
the Certificate of Correction… of Correction regarding the ’251 patent. A copy of the ’251 patent, as
corrected by the Certificate … )
SECOND AMENDED COMPLAINT FOR PATENT INFRINGEMENT
Plaintiffs Vifor Fresenius…Fresenius”) hereby assert the following claims for patent
infringement against Defendants Lupin Pharmaceuticals |
External link to document |
| 2021-02-22 |
299 |
Post Trial Brief |
“the Asserted Claims”) of U.S. Patent No. 9,561,251 (the “’251
patent”) should be found invalid as obvious…view of Orange Book-
listed U.S. Patent No. 6,174,442 (the “’442 patent”) alone or in combination with …251 patent
merely recite the sucroferric oxyhydroxide composition of Example 1 of the ’442 patent, its… in View of the ’442 Patent
“Section 103(a) forbids issuance of a patent ‘when the differences…argument based on the ’442 patent.
In cases involving patentability of new chemical compounds— |
External link to document |
| 2021-02-22 |
300 |
Proposed Findings of Fact |
and
e. U.S. Patent No. 7,465,465 (the “’465 patent”) (JTX-0004).
(Tr. 287:21-288:…’251 patent U.S. Patent No. 9,561,251 (JTX-0001)
’442 patent U.S. Patent No. 6,714,442… The ’442 Patent
27. The ’442 patent issued on January 16, 2001 from U.S. Patent Application… ’442 Patent Claimed the API and Was a Blocking Patent
323. The ’442 patent served as …that this patent covered Velphoro. (Id.)
325. Compound patents like the ’442 patent provide |
External link to document |
